February 2016 issue: Too many options, too little choice in COPD? - a podcast by BMJ Group
from 2016-02-04T08:54:33
::
::
In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the proliferation of new drugs for managing COPD; review two new lipid-lowering drugs (evolocumab and alirocumab) from a new class (proprotein convertase subtilisin/kexin type 9 inhibitors); and consider total ankle joint replacement.
The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.
Read all the articles featured here: http://dtb.bmj.com/content/54/2.toc
Further episodes of DTB podcast
Further podcasts by BMJ Group
Website of BMJ Group